![]() |
市场调查报告书
商品编码
1880645
单丝可吸收缝线市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2024-2032 年)Monofilament Absorbable Sutures Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
受全球外科手术数量不断增加以及先进伤口闭合解决方案的快速普及的推动,全球单丝可吸收缝合线市场正经历强劲增长。预计该市场规模将在 2024 年达到 5.593 亿美元,2025 年达到 5.841 亿美元,到 2032 年达到 9.327 亿美元,预测期内复合年增长率 (CAGR) 为 6.9%。这些缝合线由合成或天然材料的单根细丝製成,由于其可在体内自然溶解,无需取出,因此在内视镜手术和微创手术中至关重要。 2024年,北美凭藉先进的医疗基础设施和庞大的手术量,占了32.33%的市场占有率,占主导地位。
单丝可吸收缝线广泛应用于一般外科、骨科、心血管外科和妇科。其光滑的单股结构可减少组织摩擦,最大限度地降低炎症,从而改善癒合效果。全球对感染控制意识的提升以及微创手术的普及,进一步推动了这类缝线的需求。
市场推动因素
推动市场扩张的关键因素是全球手术数量的快速成长,涵盖骨科、心臟病学、妇产科和整形外科等领域。根据加拿大健康资讯研究所 (CIHI) 的数据,全球剖腹产率持续上升,预计2023年将达到33.4%。此外,美国国家生物技术资讯中心 (NCBI) 报告称,每年约有 40 万例冠状动脉旁路移植术。这些趋势显着增加了单丝可吸收缝合线的消耗量,而单丝可吸收缝合线对于内部伤口缝合至关重要。
此外,全球人口老化使得慢性疾病患者更容易接受手术治疗,例如血管成形术、关节置换术和器官移植。这一因素进一步推动了对可吸收缝合线的长期需求,尤其是那些旨在减少术后不适和併发症风险的缝合线。
市场限制因子
儘管预计市场将成长,但由于手术缝合器、组织黏合剂和止血剂等替代伤口缝合技术的日益普及,市场面临挑战。这些方法具有应用速度更快、感染风险更低和美观性更佳等优势。根据 Suture Planet(2025 年 2 月)的报告,与缝线相比,缝合器可加快伤口闭合速度并减少组织损伤,从而限制了单丝可吸收缝线在某些外科领域的应用。
新兴市场对价格高度敏感,且缺乏对缝线相关最佳实践的了解,也阻碍了缝合器的广泛应用。
市场机会
随着亚洲、中东和非洲等发展中国家医疗基础设施的不断完善,预计这些国家将迎来强劲的成长机会。新建医院、专科医疗中心和外科培训设施的投资增加,显着推动了对缝线的需求。例如,沙迦的 Al Qasimi 医院于 2024 年安装了先进的心臟模拟技术,印度的 Inamdar 综合医院于 2025 年开设了一家专业的牙科和脸部外科诊所。随着医疗服务可近性的提高,预计手术数量将会增加,从而促使单丝可吸收缝线的消耗量增加。
市场挑战
术后併发症(例如感染、过敏反应和肉芽肿形成)仍然是一个挑战。这些问题可能促使外科医生选择不可吸收缝线或其他缝合系统。此外,FDA 和 EMA 等监管机构实施的严格监管框架增加了研发时间和成本,尤其对于中小型製造商而言。
主要趋势
重塑市场的关键趋势是无结可吸收缝线的日益普及,尤其是在微创心血管、骨科和腹腔镜手术中。这些缝线可减少手术部位感染,并消除与结相关的併发症。临床研究,例如 2022 年发表在 "英国外科杂誌" 上的一份报告,显示与传统缝线相比,使用无结倒刺缝线可显着降低手术部位感染率。此外,抗菌涂层和生物工程单丝缝合线正在迅速普及。
The global monofilament absorbable sutures market is witnessing strong growth as surgical volumes rise worldwide and advanced wound closure solutions gain rapid acceptance. The market was valued at USD 559.3 million in 2024, is projected to increase to USD 584.1 million in 2025, and is anticipated to reach USD 932.7 million by 2032, expanding at a CAGR of 6.9% over the forecast period. These sutures, made from a single filament of synthetic or natural materials, dissolve naturally in the body and eliminate the need for removal, making them essential in internal and minimally invasive surgeries. In 2024, North America held a dominant market share of 32.33%, supported by advanced healthcare infrastructure and high surgical procedure volume.
Monofilament absorbable sutures are widely used in general surgery, orthopedics, cardiovascular procedures, and gynecology. Their smooth, single-strand design reduces tissue drag and minimizes inflammation, improving healing outcomes. Increasing global awareness around infection control and the shift towards minimally invasive procedures have further strengthened demand for these sutures.
Market Drivers
A key driver for market expansion is the rapid rise in global surgical procedures, spanning orthopedics, cardiology, obstetrics, and cosmetic surgery. Cesarean section rates continue escalating worldwide-Canada recorded 33.4% of deliveries by C-section in 2023, according to CIHI. Furthermore, the National Center for Biotechnology Information (NCBI) reports that around 400,000 coronary bypass surgeries are conducted annually. Such trends significantly increase consumption of monofilament absorbable sutures, which are crucial for internal wound closure.
Additionally, the aging global population is more susceptible to chronic diseases requiring surgical intervention, such as angioplasty, joint replacement, and organ transplantation. This factor further fuels long-term demand for absorbable sutures, especially those designed to reduce post-surgical discomfort and complication risks.
Market Restraints
Despite growth, the market faces challenges due to the rising adoption of alternative wound closure technologies, including surgical staplers, tissue adhesives, and hemostats. These methods offer advantages such as faster application, lower infection risks, and improved aesthetic outcomes. As per Suture Planet (February 2025), staplers provide faster closure and reduced tissue damage compared to sutures, which limits the use of monofilament absorbable sutures in specific surgical disciplines.
Price sensitivity in emerging markets, coupled with limited awareness of suture-related best practices, also hinders widespread adoption.
Market Opportunities
Developing countries across Asia, the Middle East, and Africa represent strong growth opportunities due to expanding healthcare infrastructure. Increasing investments in new hospitals, specialty centers, and surgical training facilities significantly boost suture demand. For instance, Al Qassimi Hospital in Sharjah adopted advanced cardiac simulation technology in 2024, while Inamdar Multispecialty Hospital in India opened a dedicated Dental & Face Surgery Clinic in 2025. As healthcare access improves, surgical volumes will rise, resulting in higher consumption of monofilament absorbable sutures.
Market Challenges
Post-surgical complications such as infection, hypersensitivity reactions, and granuloma formation continue to pose challenges. These issues may push surgeons toward non-absorbable or alternative closure systems. Moreover, stringent regulatory frameworks enforced by agencies like the FDA and EMA increase development time and cost, particularly for smaller manufacturers.
Key Trends
A major trend reshaping the market is the growing adoption of knotless absorbable sutures, especially for minimally invasive cardiovascular, orthopedic, and laparoscopic surgeries. These sutures reduce surgical site infections and eliminate knot-related complications. Clinical studies, such as the 2022 British Journal of Surgery report, highlight significant reductions in SSI rates when using knotless barbed sutures compared to conventional types. Additionally, antimicrobial-coated and bioengineered monofilament sutures are rapidly gaining traction.
Conclusion
With the market growing from USD 559.3 million in 2024 to USD 932.7 million by 2032, the monofilament absorbable sutures industry is set for sustained expansion driven by escalating surgical procedures, technological advancements, and broader healthcare access. While regulatory hurdles and competing technologies pose challenges, rising preference for minimally invasive solutions and improvements in suture design ensure strong long-term growth.
Segmentation By Type, Application, End-user, and Region
By Type * Natural
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (By Type, by Application, by End-user, and by Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa